Efficient and safe internalization of magnetic iron oxide nanoparticles: Two fundamental requirements for biomedical applications

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 4, 2014, Pages 733-743

  Calero, Macarena ^a,b   Gutiérrez, Lucía ^c   Salas, Gorka ^b,c   Luengo, Yurena ^c   Lázaro, Ana ^b   Acedo, Pilar ^a   Morales, M Puerto ^c   Miranda, Rodolfo ^a,b   Villanueva, Angeles ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b INSTITUTO MADRILEÑO DE ESTUDIOS AVANZADOS EN NANOCIENCIA IMDEA NANOCIENCIA   (Spain)

^c INSTITUTO DE CIENCIA DE MATERIALES DE MADRID   (Spain)

Author keywords

Cellular uptake; Cytoskeleton; Cytoxicity; HeLa cell line; Iron oxide magnetic nanoparticles

Indexed keywords

CELL CULTURE; COATINGS; MEDICAL APPLICATIONS; SCANNING ELECTRON MICROSCOPY; TOXICITY;

CELLULAR UPTAKE; CYTOSKELETONS; CYTOXICITY; HELA CELL LINE; MAGNETIC NANO-PARTICLES;

METAL NANOPARTICLES;

AMINODEXTRAN; AMINOPROPYLTRIETHOXYSILANE; DEXTRAN DERIVATIVE; MAGNETIC IRON OXIDE NANOPARTICLE; MAGNETIC NANOPARTICLE; ORGANOSILICON DERIVATIVE; REACTIVE OXYGEN METABOLITE; SUCCIMER; TRYPAN BLUE; UNCLASSIFIED DRUG; FERRIC ION; FERRIC OXIDE; MAGNETITE NANOPARTICLE;

ARTICLE; BIOCOMPATIBILITY; CELL CYCLE; CELL DAMAGE; CELL INTERACTION; CELL STRUCTURE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; MEDICAL TECHNOLOGY; MOLECULAR INTERACTION; MTT ASSAY; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; TRYPAN BLUE ASSAY; CHEMISTRY; METABOLISM; ULTRASTRUCTURE;

CYTOSKELETON; FERRIC COMPOUNDS; HELA CELLS; HUMANS; MAGNETITE NANOPARTICLES; REACTIVE OXYGEN SPECIES;

EID: 84900324596     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.11.010     Document Type: Article

References (58)

1. Huang J., Zhong X., Wang L., Yang L., Mao H. Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticles. Theranostics 2012, 2:86-102.
2. Pankhurst Q.A., Thanh N.K.T., Jones S.K., Dobson J. Progress in applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 2009, 42:224001.
3. Wang M., Thanou M. Targeting nanoparticles to cancer. Pharmacol Res 2010, 62:90-99.
4. Lee D.E., Koo H., Sun I.C., Ryu J.H., Kim K., Kwon I.C. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev 2012, 41:2656-2672.
5. Shubayev V.I., Pisanic Ii T.R., Jin S. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 2009, 61:467-477.
6. Pan B., Cui D., Sheng Y., Ozkan C., Gao F., He R., et al. Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. Cancer Res 2007, 67:8156-8163.
7. Qi L., Wu L., Zheng S., Wang Y., Fu H., Cui D. Cell-penetrating magnetic nanoparticles for highly efficient delivery and intracellular imaging of siRNA. Biomacromolecules 2012, 13:2723-2730.
8. Ruan J., Wang K., Song H., Xu X., Ji J., Cui D. Biocompatibility of hydrophilic silica-coated CdTe quantum dots and magnetic nanoparticles. Nanoscale Res Lett 2011, 6:1-13.
9. Cole A.J., David A.E., Wang J., Galbán C.J., Hill H.L., Yang V.C. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials 2011, 32:2183-2193.
10. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
11. Gupta A.K., Naregalkar R.R., Vaidya V.D., Gupta M. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications. Nanomedicine 2007, 2:23-39.
12. Villanueva A., Cañete M., Roca A.G., Calero M., Veintemillas-Verdaguer S., Serna C.J., et al. The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells. Nanotechnology 2009, 20:115103.
13. Arora S., Rajwade J.M., Paknikar K.M. Nanotoxicology and in vitro studies: the need of the hour. Toxicol Appl Pharmacol 2012, 258:151-165.
14. Fadeel B., Garcia-Bennett A.E. Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev 2010, 62:362-374.
15. Singh N, Jenkins GJS, Asadi R, Doak SH. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev 2010;1.
16. Wu X., Tan Y., Mao H., Zhang M. Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells. Int J Nanomedicine 2010, 5:385-399.
17. Brunner T.J., Wick P., Manser P., Spohn P., Grass R.N., Limbach L.K., et al. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 2006, 40:4374-4381.
18. Monteiro-Riviere N.A., Inman A.O., Zhang L.W. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 2009, 234:222-235.
19. Ding J., Tao K., Li J., Song S., Sun K. Cell-specific cytotoxicity of dextran-stabilized magnetite nanoparticles. Colloids Surf B 2010, 79:184-190.
20. Hong S.C., Lee J.H., Lee J., Kim H.Y., Park J.Y., Cho J., et al. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Int J Nanomedicine 2011, 6:3219.
21. Naqvi S., Samim M., Abdin M.Z., Ahmed F.J., Maitra A.N., Prashant C.K., et al. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int J Nanomedicine 2010, 5:983-989.
22. Lai C.W., Wang Y.H., Lai C.H., Yang M.J., Chen C.Y., Chou P.T., et al. Iridium-complex-functionalized Fe3O4/SiO2 core/shell nanoparticles: a facile three-in-one system in magnetic resonance imaging, luminescence imaging, and photodynamic therapy. Small 2008, 4:218-224.
23. Tartaj P., Morales M.P., Gonzalez-Carreño T., Veintemillas-Verdaguer S., Serna C.J. The iron oxides strike back: from biomedical applications to energy storage devices and photoelectrochemical water splitting. Adv Mater 2011, 23:5243-5249.
24. Roca A.G., Veintemillas-Verdaguer S., Port M., Robic C., Serna C.J., Morales M.P. Effect of nanoparticle and aggregate size on the relaxometric properties of MR contrast agents based on high quality magnetite nanoparticles. J Phys Chem B 2009, 113:7033-7039.
25. Mejías R., Gutiérrez L., Salas G., Pérez-Yagüe S., Zotes T.M., Lázaro F.J., et al. Long term biotransformation and toxicity of dimercaptosuccinic acid-coated magnetic nanoparticles support their use in biomedical applications. J Control Release 2013, 171:225-233.
26. Luengo Y., Nardecchia S., Morales M.P., Serrano M.C. Different cell responses induced by exposure to maghemite nanoparticles. Nanoscale 2013, In press.
27. De Soenen S.J., Cuyper M. How to assess cytotoxicity of (iron oxide-based) nanoparticles. A technical note using cationic magnetoliposomes. Contrast Media Mol Imaging 2011, 6:153-164.
28. Walczak C.E. Microtubule dynamics and tubulin interacting proteins. Curr Opin Cell Biol 2000, 12:52-56.
29. Critchley D.R. Focal adhesions - the cytoskeletal connection. Curr Opin Cell Biol 2000, 12:133-139.
30. Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 1999, 27:612-616.
31. Chanteau B., Fresnais J., Berret J.F. Electrosteric enhanced stability of functional sub-10nm cerium and iron oxide particles in cell culture medium. Langmuir 2009, 25:9064-9070.
32. Ito A., Fujioka M., Yoshida T., Wakamatsu K., Ito S., Yamashita T., et al. 4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma. Cancer Sci 2007, 98:424-430.
33. Soenen S.J.H., Himmelreich U., De Nuytten N., Cuyper M. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials 2011, 32:195-205.
34. Fan C., Gao W., Chen Z., Fan H., Li M., Deng F., et al. Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles. Int J Pharm 2011, 404:180-190.
35. Nazli C., Ergenc T.I., Yar Y., Acar H.Y., Kizilel S. RGDS-functionalized polyethylene glycol hydrogel-coated magnetic iron oxide nanoparticles enhance specific intracellular uptake by HeLa cells. Int J Nanomedicine 2012, 7:1903.
36. Arbab A.S., Bashaw L.A., Miller B.R., Jordan E.K., Lewis B.K., Kalish H., et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging1. Radiology 2003, 229:838-846.
37. Verma A., Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small 2010, 6:12-21.
38. Soenen S.J.H., Illyes E., Vercauteren D., Braeckmans K., Majer Z., De Smedt S.C., et al. The role of nanoparticle concentration-dependent induction of cellular stress in the internalization of non-toxic cationic magnetoliposomes. Biomaterials 2009, 30:6803-6813.
39. Kenzaoui B.H. Evaluation of uptake and transport of cationic and anionic ultrasmall iron oxide nanoparticles by human colon cells. Int J Nanomedicine 2012, 7:1275-1286.
40. Cañete M., Soriano J., Villanueva A., Roca A.G., Veintemillas S., Serna C.J., et al. The endocytic penetration mechanism of iron oxide magnetic nanoparticles with positively charged cover: a morphological approach. Int J Mol Med 2010, 26:533-539.
41. Soenen S.J.H., Himmelreich U., Nuytten N., Pisanic Ii T.R., De Ferrari A., Cuyper M. Intracellular nanoparticle coating stability determines nanoparticle diagnostics efficacy and cell functionality. Small 2010, 6:2136-2145.
42. Hoet P.H.M., Brüske-Hohlfeld I., Salata O.V. Nanoparticles - known and unknown health risks. J Nanobiotechnol 2004, 2:12.
43. Iversen T.G., Skotland T., Sandvig K. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today 2011, 6:176-185.
44. Xia J.G., Zhang S., Zhang Y., Ma M., Gu N. Maghemite nanoparticles and their protamine derivatives: cellular internalization and effects on cell-cycle progress. J Nanosci Nanotechnol 2009, 9:1025-1028.
45. Mahmoudi M., Azadmanesh K., Shokrgozar M.A., Journeay W.S., Laurent S. Effect of nanoparticles on the cell life cycle. Chem Rev 2011, 111:3407-3432.
46. Könczöl M., Ebeling S., Goldenberg E., Treude F., Gminski R., Gieré R., et al. Cytotoxicity and genotoxicity of size-fractionated iron oxide (magnetite) in A549 human lung epithelial cells: role of ROS, JNK, and NF-κB. Chem Res Toxicol 2011, 24:1460-1475.
47. Zuzana M., Alessandra R., Lise F., Maria D. Safety assessment of nanoparticles cytotoxicity and genotoxicity of metal nanoparticles in vitro. J Biomed Nanotechnol 2011, 7:20-21.
48. Khan M.I., Mohammad A., Patil G., Naqvi S.A.H., Chauhan L.K.S., Ahmad I. Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles. Biomaterials 2012, 33:1477-1488.
49. Gupta A.K., Curtis A.S.G. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture. J Mater Sci Mater Med 2004, 15:493-496.
50. Rivet C.J., Yuan Y., Borca-Tasciuc D.A., Gilbert R.J. Altering iron oxide nanoparticle surface properties induce cortical neuron cytotoxicity. Chem Res Toxicol 2012, 25:153-161.
51. Berry C.C., Wells S., Charles S., Curtis A.S.G. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 2003, 24:4551-4557.
52. Apopa P.L., Qian Y., Shao R., Guo N.L., Schwegler-Berry D., Pacurari M., et al. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part Fibre Toxicol 2009, 6:1.
53. Soenen S.J.H., Nuytten N., De Meyer S.F., De Smedt S.C., De Cuyper M. High intracellular iron oxide nanoparticle concentrations affect cellular cytoskeleton and focal adhesion kinase-mediated signaling. Small 2010, 6:832-842.
54. Horie M., Kato H., Fujita K., Endoh S., Iwahashi H. In vitro evaluation of cellular response induced by manufactured nanoparticles. Chem Res Toxicol 2012, 25:605-619.
55. Hoskins C., Cuschieri A., Wang L. The cytotoxicity of polycationic iron oxide nanoparticles: common endpoint assays and alternative approaches for improved understanding of cellular response mechanism. J Nanobiotechnol 2012, 10:15.
56. Mahmoudi M., Hofmann H., Rothen-Rutishauser B., Petri-Fink A. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem Rev 2012, 112:2323-2338.
57. Lanone S., Rogerieux F., Geys J., Dupont A., Maillot-Marechal E., Boczkowski J., et al. Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines. Part Fibre Toxicol 2009, 6:1-12.
58. Laurent S., Burtea C., Thirifays C., Häfeli U.O., Mahmoudi M. Crucial ignored parameters on nanotoxicology: the importance of toxicity assay modifications and "cell vision". PLoS One 2012, 7:e29997.